Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by Vinny57on Jul 25, 2019 2:08pm

151 Views

Post# 29960295

RE:People will be upset with this post but, one cannot argue

The reason for the lackluster results of Aphria???? The other company's CEOs weren't caught with their hands in the cookie jar. Aphria still carries an "I wouldn't touch that company with a 10 foot pole" stigma attached to it. You can thank Vic, John, and Cole for that. While it pains me to see the share price decline day after day, I still believe it has the best chance of all the LPs for a massive increase in share price. We all know the reasons why and they have been listed here by many other posters. I am getting close to the break even point after being up well over $1 mil. last year. However, I am still 100% invested. I've seen $24 and I've seen under $5, as many of you have. Should I have sold at $24?....of course. Should I have bought at $5?.... of course. Captain Hindsight would have been nice to know.

So what now? In the last couple of years we have seen the share price double and triple in only a few short weeks. Can that happen again?.....of course. We all know and are waiting for Aphria's "Good news". We are due.....over due. Do you want to miss out after enduring all the hurdles and waiting so long for the prize..........I don't.

Daredevil1964 wrote: with the results. I am basing this on a long term investment sonce
November of 2017 and doing some comparison.

Ticker Share Price Nov. 1 2017 Current Share Price.
ACB 2.99-3.00 CAD 8.70 CAD
WEED 16,20-16.30 CAD 46.90 CAD
APHA 7.80-7.90 CAD 7.96 CAD
CRON 3.40-3.50 CAD 20.05 CAD
OGI 3.00-3.10 CAD 7.75 CAD

Of these 5 as a long term investment Aphria is trading at the same share price as it was back in Nov. 1 2017. I chose these 5 becsuse other names like HEXO ant TRST were not trading back on Nov. 1 of 2017.

This hurts. As an argument that Long term investing wins out, well for 1 and 3/4 years now Aphria has not shown the same gains over the same time frame as the others. This is hard to look at and comprhend. Sorry, these are the facts, the chart is not lying. We really need Irwin to step up here and for my sake I hope he does.